Novartis to Acquire RNA Therapeutics Innovator Avidity Biosciences for $12 Billion to Bolster Neuroscience and Muscle Disease Pipeline image
2 min read

Novartis to Acquire RNA Therapeutics Innovator Avidity Biosciences for $12 Billion to Bolster Neuroscience and Muscle Disease Pipeline

Pharm'Up
Novartis announced a definitive agreement to acquire Avidity Biosciences, Inc. (Nasdaq: RNA), a San Diego-based biopharmaceutical company...
Read More Read more about Novartis to Acquire RNA Therapeutics Innovator Avidity Biosciences for $12 Billion to Bolster Neuroscience and Muscle Disease Pipeline
USFDA Approves GSK’s Blenrep for Relapsed/Refractory Multiple Myeloma, Showing Superiority Over Daratumumab-based Regimen image
2 min read

USFDA Approves GSK’s Blenrep for Relapsed/Refractory Multiple Myeloma, Showing Superiority Over Daratumumab-based Regimen

Pharm'Up
GSK plc has announced that the US Food and Drug Administration (FDA) has granted approval for Blenrep...
Read More Read more about USFDA Approves GSK’s Blenrep for Relapsed/Refractory Multiple Myeloma, Showing Superiority Over Daratumumab-based Regimen
Mazdutide, a Dual GLP-1/GCG Agonist, Demonstrates Superiority Over Semaglutide in Glycemic Control and Weight Loss for Type 2 Diabetes Patients image
2 min read

Mazdutide, a Dual GLP-1/GCG Agonist, Demonstrates Superiority Over Semaglutide in Glycemic Control and Weight Loss for Type 2 Diabetes Patients

Pharm'Up
Innovent Biologics announced that its fourth Phase 3 clinical trial, DREAMS-3, evaluating the novel drug mazdutide in...
Read More Read more about Mazdutide, a Dual GLP-1/GCG Agonist, Demonstrates Superiority Over Semaglutide in Glycemic Control and Weight Loss for Type 2 Diabetes Patients
Merck’s Combo Therapy KEYTRUDA + WELIREG Hits Primary Endpoint in Kidney Cancer Adjuvant Trial (LITESPARK-022) image
2 min read

Merck’s Combo Therapy KEYTRUDA + WELIREG Hits Primary Endpoint in Kidney Cancer Adjuvant Trial (LITESPARK-022)

Pharm'Up
Merck (known as MSD outside North America) has announced positive top-line results from its Phase 3 LITESPARK-022...
Read More Read more about Merck’s Combo Therapy KEYTRUDA + WELIREG Hits Primary Endpoint in Kidney Cancer Adjuvant Trial (LITESPARK-022)
Teva Settles QVAR Antitrust Case for $35 Million and Agrees to Withdraw Patents, Resolving Generic Delay Claims image
2 min read

Teva Settles QVAR Antitrust Case for $35 Million and Agrees to Withdraw Patents, Resolving Generic Delay Claims

Pharm'Up
Teva Pharmaceuticals USA, Inc., has agreed to a $35 million settlement to resolve a class action lawsuit...
Read More Read more about Teva Settles QVAR Antitrust Case for $35 Million and Agrees to Withdraw Patents, Resolving Generic Delay Claims
Researchers Uncover ‘Perineural Pathway’ Allowing HIV to Escape the Brain and Reseed the Body Despite Antiretroviral Therapy image
2 min read

Researchers Uncover ‘Perineural Pathway’ Allowing HIV to Escape the Brain and Reseed the Body Despite Antiretroviral Therapy

Pharm'Up
New research published in The American Journal of Pathology by investigators from Boston College and the Tulane...
Read More Read more about Researchers Uncover ‘Perineural Pathway’ Allowing HIV to Escape the Brain and Reseed the Body Despite Antiretroviral Therapy

Read These Too

Pharm up 38
2 min read

Sun Pharma Hiring Senior Executive – Production QMS Supervisor in Jammu

Pharm'Up
Pharm up 37
1 min read

Pfizer Hiring Associate Manager – MQA Downstream in Vizag

Pharm'Up
Pharm up 36
1 min read

Aster CMI Hospital Hiring Clinical Pharmacist in Bangalore

Pharm'Up
Pharm up 35
2 min read

Amneal Pharmaceuticals Hiring Senior Executive – Clinical Affairs in Ahmedabad

Pharm'Up